Skip to content
healthcare.dev

Erzofri extended-release

NDC 72526-105, paliperidone palmitate, injection, from Shandong Luye Pharmaceutical Co., Ltd..

Product NDC
72526-105
Status
Listed
Labeler
Shandong Luye Pharmaceutical Co., Ltd.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216352
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72526-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE PALMITATE39 mg/.25mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
72526-105-11725260105111 SYRINGE, GLASS in 1 KIT (72526-105-11) / .25 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/492bf9dd-868e-421a-92db-8cca8973aac1
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72526-105

Use it

Look up 72526-105 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72526-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72526-105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.